The Latest in Lymphoma & Plasma Cell Disorders

Age limits restrict AYA participation in relevant trials

October 22, 2018

Study supports sequencing in kids with cancer

October 19, 2018

BTK inhibitor shows early promise for WM

October 18, 2018

sNDA gets priority review for CLL/SLL

October 18, 2018

Understanding the role of HSCT in PTCL

October 17, 2018

FDA issues draft guidance on MRD

October 16, 2018

Inhibitor receives orphan designation for PTCL

October 11, 2018

Phase 1 NHL, ALL trials placed on clinical hold

October 10, 2018

Variant not associated with CLL, AIHA, or ITP in certain patients

October 8, 2018

System may better predict thrombosis in lymphoma

October 8, 2018

Weighing the costs of CAR T-cell therapy

October 7, 2018

CAR T therapy being explored in Hodgkin lymphoma

October 6, 2018

Duvelisib bests ofatumumab as monotherapy for treatment of CLL/SLL

October 5, 2018

5-year remission rates with combo prove durable in MCL

October 4, 2018

Ground-breaking therapy comes with distinct challenges

October 2, 2018